Advancing Drug Development by Reducing Reliance on Animal Testing. Case Example: Pre-Clinical

DURHAM, N.C., Aug. 27, 2025 (GLOBE NEWSWIRE) — Aer Therapeutics (“Aer”), a

Study AER-01-002 is using a novel and precision imaging strategy to enroll

Supported by premier life science industry investors Canaan, OrbiMed, and Hatteras Venture